Dr. Ian Wilson is a researcher at Newcastle University with a focus on medical genetics, nephrology, and genomic analysis. His work spans genetic determinants of kidney diseases, mitochondrial disorders, and biomarker development. Notable contributions include studies on uromodulin genetics in African populations, copy-number variations in rare diseases, and kidney ciliopathies. He has collaborated extensively on projects involving genome sequencing, mitochondrial replacement therapy, and muscular dystrophy biomarkers. Wilson's research integrates computational tools like machine learning for predictive modeling in urolithiasis and employs advanced imaging techniques for disease progression monitoring. Key areas: Genetic epidemiology, renal genomics, mitochondrial DNA analysis Focus on translational applications: Biomarker development for kidney stones and muscular dystrophies Interdisciplinary collaborations in ophthalmology and orthopedics His publications reflect a commitment to advancing diagnostic accuracy and understanding complex genetic disorders through multi-omics approaches.
Prof. Yon Visell is an Associate Professor at the University of California, Santa Barbara (UCSB) with appointments in the Department of Bioengineering, Department of Electrical and Computer Engineering, and Department of Mechanical Engineering. He directs the RE Touch Lab, which focuses on haptics, robotics, and interactive technologies, including sensorimotor augmentation, soft robotics, and virtual reality applications. The lab is affiliated with the Media Arts and Technology Program, Communication and Signal Processing group (ECE), Dynamic Systems and Control group (ME), California NanoSystems Institute, Center for Polymers and Organic Solids, UCSB Research Center for Virtual Environments and Behavior, and UCSB Robotics Group. Education: PhD in Electrical and Computer Engineering from McGill University, MA in Physics from University of Texas, Austin, and BA in Physics from Wesleyan University His research spans robotics, haptics, biomechanics, and soft electronics, aiming to advance human-computer interaction and wearable technologies. Recent work includes light-driven tactile displays, biomechanical filtering in tactile encoding, and haptic systems for VR and healthcare. The lab has received numerous awards at IEEE Haptics Symposium, World Haptics Conference, and EuroHaptics Society events. 2025 Best Demonstration Awards at IEEE World Haptics Conference 2024 Best Paper at IEEE Haptics Symposium 2023 Best Journal Paper at IEEE Transactions on Haptics Visell's group has pioneered wave-based haptic rendering, tactile holography, and soft wearable robotics. They have developed tools like SkinSource for tactile biomechanics simulation and collaborated with institutions in North America, Europe, and Japan. Current projects involve photonics-driven tactile systems, soft robotics for therapy, and next-generation haptic interfaces while mentoring students like Gregory Reardon (2024 EuroHaptics Best Dissertation), Max Linnander (IEEE Haptics awards), and Neeli Tummala (SWE Intel Scholar). Research Grants: Funded by NSF, tech, and healthcare industries Lab: RE Touch Lab at California NanoSystems Institute Collaborations: with TU Dresden, Northwestern University, NC State, UCLA, and others
Dr James Herbert-Read is an Associate Professor and Whitten Lecturer in Marine Biology at the Department of Zoology, University of Cambridge. He serves as Deputy Head of Department (Postgraduate Education) and leads the Marine Behavioural Ecology Group. His research focuses on understanding how animals, particularly marine organisms, collect and process information from their environments to make behavioral decisions, with emphasis on social interactions, adaptation mechanisms, and ecological constraints. His group employs theoretical frameworks, controlled experiments, and quantitative field studies to investigate behavioral diversity in marine species. Key themes include collective behavior, predator-prey dynamics, camouflage strategies, and the impacts of environmental stressors on animal decision-making. Recent publications highlight work on lionfish vocalization mechanisms, cuttlefish camouflage, citizen science applications in marine research, and behavioral responses to visual and acoustic noise. Scientific awards and affiliations include: Whitten Lecturer in Marine Biology Associate Professor, University of Cambridge He has supervised research projects on topics such as: Social attraction in invasive fish species Evolution of coordinated movement Neurophysiological basis for leadership in shoals Maternal effects on offspring exploration
Dr Thomas Maguire is a Visiting Fellow with the King's Intelligence and Security Group in the Department of War Studies at King's College London, and Assistant Professor of Intelligence and Security at Leiden University. His research focuses on intelligence-propaganda interactions and international security cooperation, particularly in Cold War Southeast Asia and counter-terrorism contexts. Education: PhD in International Relations (POLIS, University of Cambridge) MPhil in International Relations (POLIS, University of Cambridge) BA (Hons) in History (Durham University) Maguire's research examines the intersection of intelligence operations and propaganda dissemination in foreign policy contexts, with specialized focus on British and American covert action in Southeast Asia. He also investigates post-colonial security relationships and international counter-terrorism cooperation frameworks. His work spans historical analysis and contemporary security challenges. Maguire's publications demonstrate interdisciplinary research across public health, virology, and immunology, particularly addressing COVID-19 diagnostics, vaccine development, and immune responses. This reflects methodological versatility in addressing complex global security and health challenges through both historical analysis and biomedical research. Scientific Awards: Lisa Smirl Prize for best thesis (University of Cambridge) Maguire leads the Dutch Government-funded 'Sharing Secrets' project investigating intelligence disclosure decision-making. He teaches intelligence studies courses and co-convenes the Cambridge Intelligence Seminar. At Leiden, he coordinates undergraduate and postgraduate programs in Intelligence Studies and Crisis Management. Maguire previously served as Research Fellow at Darwin College and the Department of Politics and International Studies (University of Cambridge), and as John Garnett Visiting Fellow at the Royal United Services Institute focusing on East African security challenges.
Christian P Petersen, PhD is a Professor in the Department of Cell and Developmental Biology at the Weinberg College of Arts and Sciences , Northwestern University Feinberg School of Medicine. His research focuses on molecular mechanisms underlying regeneration in planarians and other organisms. PhD: MIT (2006) Research Interests: Planarian regeneration and tissue patterning Wnt signaling pathway regulation Stem cell biology in regenerative contexts Neurogenesis and injury response Molecular mechanisms of tissue repair Affiliations: Center for Reproductive Science Robert H. Lurie Comprehensive Cancer Center
Dr. Darryl Dickerson is an Assistant Professor in the Department of Mechanical and Materials Engineering at Florida International University (FIU), part of the College of Engineering. His research focuses on mechanical characterization of biological interfaces, design of bioinspired materials, and advancing inclusive engineering education practices. He holds a Ph.D. (details not explicitly provided in text). Research Interests: Dr. Dickerson’s work bridges biomechanics and biomaterials engineering with social equity in education. Key areas include: Mechanical properties of biological interfaces (e.g., bone-cartilage junctions) Development of biomaterials for tissue repair using 3D printing and electrospinning Anti-marginalization strategies in engineering education, particularly for Black and Brown students Publications Trends: Recent work emphasizes dual themes: (1) Biomedical innovation through advanced material fabrication and (2) Inclusive pedagogy addressing systemic inequities in STEM education. Notable contributions include scaffold designs for osteochondral repair and frameworks for reducing microaggressions in team-based learning. Grants and Advising: No specific grants or advisees listed in the provided text. His work appears to be grant-funded through NIH/National Science Foundation pathways common in biomaterials and education research. Labs and Teams: While not explicitly stated, his research likely involves collaborations with FIU’s Center for Engineering and Computing’s diversity initiatives and biomaterials labs focusing on tissue engineering applications.
Theresa Raimondo is the Manning Assistant Professor of Engineering at Brown University, with a secondary appointment in the Division of Biology and Medicine. She joined the Brown Engineering faculty in January 2024 after completing her postdoctoral training at MIT's Koch Institute. Dr. Raimondo leads the Raimondo Research Lab, which focuses on chemically modifying RNA and designing nanoparticles for therapeutic delivery to the body, an immunotherapy concept that holds immense promise in the field of immunoengineering. Her educational background includes: PhD in Engineering Sciences – Bioengineering from Harvard University (2019) MEng from Harvard University (2019) Sc.B. in Chemical and Biochemical Engineering from Brown University (2011) Dr. Raimondo's research is broadly focused on the design of targeted drug-delivery vectors and novel RNA-based therapeutics for applications in cancer, immunotherapy, and tissue regeneration. Her work primarily centers on developing novel lipid nanoparticles (LNPs) for RNA-based therapies, contributing to adjuvanted mRNA-based vaccines and siRNA-based cancer immunotherapies. By optimizing LNP formulation and modulating RNA constructs, she seeks to understand how RNA-LNPs modulate immunity and develop new therapeutic approaches. Her expertise spans biomaterials, drug delivery, biomolecular engineering, nanomedicine, tissue engineering, and regenerative medicine. Analysis of Dr. Raimondo's recent publications reveals a strong focus on RNA delivery systems and lipid nanoparticle technology. Her work spans from fundamental studies on nanoparticle design to applications in cancer immunotherapy, vaccine development, and tissue regeneration. A significant portion of her research involves optimizing lipid formulations for improved mRNA delivery and exploring how these systems interact with the immune system. Her publications demonstrate a trajectory from basic biomaterials research to increasingly translational work with therapeutic applications. Dr. Raimondo has received numerous prestigious awards: 2025 NAE Symposium selection (Grainger Foundation Frontiers of Engineering) 2025 appointment to the inaugural Early Career Board of ACS Applied Bio Materials 2024 selection as MIT Faculty Founder Initiative finalist 2022 Convergence Scholar fellowship from MIT's Marble Center for Cancer Nanomedicine National Science Foundation graduate research fellowship Harvard's Smith family graduate fellowship Dr. Raimondo is actively involved in mentoring students through courses including ENGN 0931L - Biomedical Engineering Design and Innovation II, ENGN 1490 - Biomaterials, and ENGN 1931L - Biomedical Engineering Design and Innovation II. Her research program is supported by various grants, though specific funding sources aren't detailed in the provided text. The Raimondo Research Lab represents a dynamic environment where engineering principles are applied to solve complex biological challenges in drug delivery and regenerative medicine. The Raimondo Research Lab at Brown University serves as a hub for innovation in RNA delivery and biomaterials design. The lab brings together expertise in chemical engineering, molecular biology, and immunology to develop next-generation therapeutic platforms. Current research directions include optimizing lipid nanoparticle formulations, exploring novel RNA modifications, and investigating immune responses to RNA therapeutics across various disease contexts.
Ben Cosgrove is an Associate Professor in the Meinig School of Biomedical Engineering at Cornell University, serving as Director of Graduate Studies. His research focuses on systems bioengineering approaches to understand muscle stem cell dysfunction in aging and disease. He leads the Cosgrove Lab, a multidisciplinary group integrating biomedical engineering, stem cell biology, and systems biology to study microenvironmental signaling in muscle regeneration. His work includes developing biomimetic microenvironments for stem cell manufacturing and improving regenerative medicine therapies. Dr. Cosgrove holds a B.Eng. from the University of Minnesota (2003) and a Ph.D. in Bioengineering from MIT (2009). Postdoctoral training at Stanford University (with Dr. Helen Blau) followed. His research is supported by NIH grants (including R01, R21), the Glenn Medical Research Foundation, and others. He has been recognized with awards such as the BMES Graduate Research Award (2008), Rising Star Award (2015), and Swanson Teaching Excellence Award (2019). Research interests span bioengineering, biomechanics, computational science, and systems biology. His lab's innovations include spatial transcriptomic mapping and high-yield stem cell expansion platforms. Current projects aim to decode stem cell-niche interactions to treat muscle degeneration and aging. Grants: NIH K99/R00, R01, R21; Glenn Medical Research Foundation Labs/Teams: Cosgrove Lab (Cornell University) Future Work: Expanding applications of spatial transcriptomics and engineering regenerative therapies for muscle diseases
Kristina Schoonjans is an Associate Professor at EPFL’s School of Life Sciences, where she leads the Laboratory of Metabolic Signaling (UPSCHOONJANS). Her research focuses on the molecular mechanisms of bile acid signaling, nutrient sensing, and intermediary metabolism, particularly in the context of metabolic disorders such as obesity, fatty liver disease, and cancer. She investigates how the liver-gut-brain axis integrates metabolic signals through nuclear receptors and mitochondrial dynamics. Her research interests include: Bile acid signaling and its role as a hormonal regulator Nutrient and metabolite sensing in energy homeostasis Intermediary metabolism and metabolic disorders Role of nuclear receptors (e.g., TGR5, LRH-1) in liver, gut, and adipose tissue Mitochondrial dynamics and fission in metabolic regulation Organoid models for studying liver and intestinal metabolism Systems genetics using BXD mouse populations The most recent articles highlight a strong focus on bile acid signaling, particularly through TGR5 and LRH-1, in regulating metabolic health. Themes include the conversion of white fat to beige fat (beiging), hepatic tumorigenesis, mitochondrial fission, and the use of organoid and genetically engineered mouse models. There is a consistent emphasis on translational applications for obesity, fatty liver disease, and cancer. Scientific honors include: Windaus Prize from the Dr. Falk Foundation (2010, shared with Johan Auwerx) for the discovery of the signaling/endocrine function of bile acids Prof. Schoonjans actively supervises PhD students and has advised numerous doctoral candidates who have since completed their theses. Her lab is supported by multiple grants from Swiss and international funding agencies, including the Swiss National Science Foundation, EPFL, CONACYT, and the Foundation for Health and Education. She teaches in several doctoral programs at EPFL, including Life Sciences Engineering, and contributes to education through the SSV and EDBB/EDCB/EDMS-ENS programs. The Schoonjans Lab brings together scientists, doctoral assistants, and technicians working on projects related to metabolic signaling. The team uses advanced techniques such as genetically modified mouse models, organoid cultures, and multi-omics (metabolomics, proteomics, transcriptomics) to study the liver-gut and brain-liver axes. The lab has a strong track record of high-impact publications and collaborations with institutions worldwide.
Andrew L. Feldman, MD , is a Professor of Laboratory Medicine and Pathology at Mayo Clinic, Rochester, Minnesota. He specializes in the molecular pathogenesis of T-cell lymphomas, focusing on genetic abnormalities, biomarkers, and individualized therapies. His work bridges next-generation sequencing (NGS) infrastructure and translational research to improve lymphoma diagnosis and subclassification. Primary Appointment: Consultant, Division of Hematopathology Joint Appointment: Consultant, Division of Experimental Pathology and Laboratory Medicine Education: MD, Brown University (1991) BA, Brown University (1986) Clinical Fellowship, Hematopathology, National Cancer Institute (2006) Research Interests: Dr. Feldman's research explores the genetic basis of T-cell lymphomas, which are often fatal. By characterizing mutations (e.g., DUSP22 , TP63 , STAT3 ) and applying bioinformatics, his team develops diagnostic tests to predict therapeutic responses. He also investigates how genetic heterogeneity impacts lymphoma classification and treatment strategies. Scientific Awards: Berard-Dorfman Founders Award, Society for Hematopathology (2015) Recipient Medal, Pedro Ruiz Gallo National University, Peru (2007) Artemis Fellowship, Nikolas Symposium XV, Athens (2005) NIH Fellows Award for Research Excellence (2003, 2000) First Prize, Resident Paper Competition (1999) Daland Award, New England Cancer Society (1999) Outstanding Junior Resident Teaching Award (1996) Joseph Collins Foundation Scholarship (1988) Advising and Grants: Dr. Feldman has directed the Mayo Clinic Biospecimens Core and led NCI-funded projects like the Lymphoma Specialized Program of Research Excellence (SPORE) and Molecular Classification of Anaplastic Large Cell Lymphoma . He has served on NCI Lymphoma Steering Committee and Mayo Clinic's NGS Infrastructure Subcommittee. Laboratory and Collaborations: His lab collaborates with the International Lymphoma Study Group , Mayo Clinic Comprehensive Cancer Center , and Association for Molecular Pathology . He co-developed clinical trials linking molecular profiling to therapeutic targets and contributed to the Lymphoma/Leukemia Molecular Profiling Project (LLMPP) Research Consortium.
Gustavo Nader, Ph.D., is a Professor of Kinesiology at The Pennsylvania State University's College of Health and Human Development, where he holds the Dorothy Foehr Huck and J. Loyd Huck Endowed Chair in Molecular, Cellular and Integrative Physiology. His research laboratory at 101 Noll Lab focuses on molecular mechanisms of skeletal muscle adaptation, employing human, animal, and cellular models to investigate ribosome biogenesis, transcriptional regulation, and muscle growth control in contexts ranging from exercise hypertrophy to cancer cachexia. Dr. Nader's research examines fundamental processes including: Ribosome biogenesis and its role in muscle growth regulation Epigenetic control of RNA Polymerase I activity Molecular pathways in mechanical overload-induced hypertrophy Tumor-induced muscle wasting mechanisms Biomimicry approaches inspired by hibernator physiology His work spans exercise physiology, cancer biology, and environmental stress responses. Analysis of his 15 most recent publications (2015-2025) reveals predominant themes in muscle hypertrophy mechanisms, cancer cachexia pathophysiology, ribosomal function analysis, and environmental stress impacts on muscle. His work consistently integrates molecular techniques with physiological models across species. Notable scientific recognitions include: Dorothy Foehr Huck and J. Loyd Huck Chair appointment (2024) Huck Institutes Leadership Fellowship (2025-2026) Dr. Nader leads an active research team investigating muscle plasticity, with current projects funded through the Huck Institutes of the Life Sciences. He collaborates extensively through Penn State's Integrative and Biomedical Physiology graduate program and Center for Cellular Dynamics.
Matei Ciocarlie is an Associate Professor of Mechanical Engineering at Columbia University, focusing on robotics research spanning hardware design, control systems, and human-robot interaction. His work emphasizes robots operating in dynamic, unstructured environments, with applications in manufacturing, logistics, and healthcare. He holds affiliations with Columbia's School of Engineering and Applied Science and the Robotics Department. Education: Ph.D. in Mechanical Engineering from Columbia University (2010), with a doctoral dissertation on dexterous robotic grasping awarded the 2010 Robotdalen Scientific Award. Research Interests: Robotic hand design/control, human-in-the-loop manipulation, assistive robotics, tactile sensing, and rehabilitation technologies. His lab develops systems like wearable robotic orthoses for stroke patients and teleoperated robots with autonomous decision-making capabilities. Awards: IEEE Early Career Award (2015), ONR Young Investigator Award (2016), NSF CAREER Award (2016), Sloan Fellowship (2017). Grants & Collaborations: Led projects at Willow Garage and Google, contributing to ROS development. Current work includes NSF-funded tactile sensing research and NIH-sponsored assistive robotics initiatives. Labs: Active projects in Columbia's Robotics Lab and collaboration with medical institutions for clinical trials of robotic orthoses.
Paula Ravasco is an Associate Professor at the Católica Medical School , Catholic University of Portugal , and a Researcher at the Center for Interdisciplinary Research in Health (CIIS) . She is a Medical Doctor specializing in Immuno-haematology and Haemotherapy, a Nutritionist with expertise in Clinical Nutrition, and holds a PhD in 'Cancer: metabolic dysfunction, nutrition and Quality of Life'. International postgraduate studies in clinical nutrition, research methodologies, and immunity-nutrition interactions Coordinator of international advanced training programs in Nutrition, Metabolism, and Cancer Faculty member of the European Society for Clinical Nutrition and Metabolism (ESPEN) Her research focuses on nutritional interventions in oncology, with emphasis on vitamin D supplementation , sarcopenia in cancer patients , and synbiotics in colorectal cancer treatment . Recent work includes systematic reviews on nutritional biomarkers, patient outcomes, and quality of life improvements through noninvasive monitoring. Key projects include NutriCancerMonitor for multidimensional nutritional monitoring during cancer treatment and the Vulneráveis mais vulneráveis initiative addressing inflammatory risk in homeless populations during the COVID-19 pandemic. Her collaborations span national and international institutions, with a focus on nutrition-oncology intersections , geriatric nutritional care , and systematic review methodologies . She contributes to UN Sustainable Development Goals (SDGs) through educational programs and nutritional research.
Xenophon Papademetris is a Professor of Biomedical Informatics & Data Science and Radiology & Biomedical Imaging at Yale School of Medicine. He serves as Associate Director of Biomedical Imaging Data Sciences at Yale Biomedical Imaging Institute and directs the Medical Software and Medical Artificial Intelligence Certificate Program. PhD in Electrical and Information Sciences from Yale University (2000) BA from Cambridge University (1994) Postdoctoral Fellowship at Yale University (2002) His research focuses on medical image analysis, machine learning, and biomedical software development. He has developed tools like BioImage Suite Web and contributed to standards committees at the Association for the Advancement of Medical Instrumentation (AAMI). His work spans modalities including MRI, CT, PET, and optical imaging. Recent publications emphasize neuroimaging analysis, explainable AI in healthcare, and multimodal data integration across species. He leads NIH-funded research under the BRAIN Initiative (R24 MH114805) and has authored a textbook on Medical Software published by Cambridge University Press. IEEE Senior Member Yale Brown-Coxe Postdoctoral Fellowship Harding Bliss Prize for Excellence in Engineering He directs the BioImage Suite Project, creating web-based image analysis tools using JavaScript and WebAssembly. His teaching includes both academic courses and a Coursera program on Medical Software with over 14,000 enrollments.
Amy Catherine Rowat is a full Professor in the Department of Integrative Biology and Physiology at UCLA's College of Letters and Science. She directs an interdisciplinary research program that integrates mechanobiology, microfluidics, cancer biophysics and food engineering to understand how physical forces shape cell behavior and to develop sustainable biotechnologies. Education & Affiliations: Professor, Department of Integrative Biology and Physiology, UCLA Member, UCLA College of Letters and Science Research Interests: Rowat's group deciphers how mechanical properties of cells and their nuclei influence disease progression and therapeutic response. Using high-throughput microfluidic deformability cytometry, her team discovered that cancer cells become stiffer and more invasive upon β-adrenergic signaling, linking stress hormones to metastatic potential. Parallel efforts focus on nuclear envelope mechanics, showing that histone H1.0 and transient nuclear deformation modulate chromatin structure and cell reprogramming. Beyond biomedicine, Rowat pioneers biophysical approaches for sustainable food production. She engineers edible scaffolds and emulsion-templated microcarriers to culture meat at scale, demonstrating spontaneous fusion of adipogenic and myogenic microtissues into marbled steak-like constructs. Recent Article Trends (2020-2025): Her latest publications reveal a cohesive trajectory: coupling mechanobiology to epigenetic regulation (viscoelastic matrix enhances chromatin remodeling), advancing single-cell mechanical phenotyping (optomagnetic arrays, high-throughput screens), translating findings to cancer therapy (β-blockers to sensitize chemotherapy) and expanding engineered foods (scalable cultured-meat bioprocessing). Funding & Awards: NIH R21 CA245667 (PI) – Repurposing beta-blockers to improve chemotherapy response (2021-2023) Laboratory & Teams: Rowat leads an active research laboratory at UCLA that trains graduate students and postdocs at the intersection of physics, engineering and biology. The lab maintains collaborations across UCLA Engineering, Jonsson Comprehensive Cancer Center, and external partners in food science and biotechnology companies.
